Literature DB >> 19191719

New European guidelines for cardiovascular disease prevention in clinical practice.

Guy De Backer1.   

Abstract

In 2007, the Fourth Joint European Societies' Task Force on cardiovascular disease (CVD) prevention in clinical practice issued an update of the guidelines on how to prevent CVD. These guidelines are endorsed by 10 international societies interested in the subject. Particular attention is given to lifestyle changes, risk factor management, and the use of cardioprotective drugs. In this paper, the content of the guidelines is summarized with emphasis on what is new compared to the previous version and on what could be of particular interest to clinical chemists. For those who would like to read more on this, please refer to the full document (112 pages including 1105 references).

Entities:  

Mesh:

Year:  2009        PMID: 19191719     DOI: 10.1515/CCLM.2009.038

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus.

Authors:  S van Dieren; U Nöthlings; Y T van der Schouw; A M W Spijkerman; G E H M Rutten; D L van der A; D Sluik; C Weikert; H G Joost; H Boeing; J W J Beulens
Journal:  Diabetologia       Date:  2010-10-20       Impact factor: 10.122

2.  The effect of problem-based learning in patient education after an event of CORONARY heart disease--a randomised study in PRIMARY health care: design and methodology of the COR-PRIM study.

Authors:  Anita Kärner; Staffan Nilsson; Tiny Jaarsma; Agneta Andersson; Ann-Britt Wiréhn; Peter Wodlin; Lisa Hjelmfors; Pia Tingström
Journal:  BMC Fam Pract       Date:  2012-11-20       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.